TRCT
IMI

Tower Research Capital (TRC)’s Intermolecular, Inc. IMI Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-319
Closed – – 4675
2018
Q3 		$0 Buy
319
+104
+48% +$149 ﹤0.01% 4524
2018
Q2 		$0 Sell
215
-1,135
-84% -$1.55K ﹤0.01% 4335
2018
Q1 		$2K Sell
1,350
-305
-18% -$434 ﹤0.01% 3020
2017
Q4 		$2K Buy
+1,655
New +$1.99K ﹤0.01% 3285
2017
Q3 		– Sell
-13,648
Closed -$12K – 4343
2017
Q2 		$12K Buy
13,648
+7,071
+108% +$6.18K ﹤0.01% 1537
2017
Q1 		$6K Sell
6,577
-11,355
-63% -$11.9K ﹤0.01% 2150
2016
Q4 		$17K Buy
+17,932
New +$17.6K ﹤0.01% 2305
2016
Q3 		– Sell
-6,782
Closed -$10K – 4915
2016
Q2 		$10K Buy
6,782
+548
+9% +$1.11K ﹤0.01% 2868
2016
Q1 		$16K Buy
+6,234
New +$14.1K ﹤0.01% 1534
2015
Q4 		– Sell
-9,683
Closed -$18K – 5371
2015
Q3 		$18K Buy
+9,683
New +$20.3K ﹤0.01% 1842
2015
Q1 		– Sell
-174
Closed – – 5187
2014
Q4 		$0 Buy
174
+108
+164% +$230 ﹤0.01% 5031
2014
Q3 		$0 Buy
+66
New +$151 ﹤0.01% 5119
2014
Q1 		– Sell
-1,578
Closed -$8K – 5184
2013
Q4 		$8K Sell
1,578
-401
-20% -$2.26K ﹤0.01% 3231
2013
Q3 		$11K Buy
1,979
+1,808
+1,057% +$11.4K ﹤0.01% 3168
2013
Q2 		$1K Buy
+171
New +$1.46K ﹤0.01% 3785

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tower Research Capital (TRC)'s IMI Position: Q4 2018 in Review

Tower Research Capital (TRC) sold out of Intermolecular, Inc. (IMI) in Q4 2018, closing a stake of 319 shares.

Tower Research Capital (TRC) first reported a position in IMI in Q2 2013 and held it in 15 quarters. The position peaked at $18K in Q3 2015. 32 funds tracked by Wall St. Rank hold IMI as of Q4 2018.

  • Tower Research Capital (TRC) reported no remaining Intermolecular, Inc. position as of Q4 2018 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 319 Intermolecular, Inc. shares in Q4 2018.
  • Tower Research Capital (TRC) first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 15 quarters.
  • Tower Research Capital (TRC)'s Intermolecular, Inc. position peaked at $18K in Q3 2015.
  • 32 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q4 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.